Europe — EMA
Lenalidomid Teva
GNH USA supplies Lenalidomid Teva (Lenalidomide), an antineoplastic for multiple myeloma, myelodysplastic syndromes, mantle cell lymphoma. Request a quote.
Request sourcing
What is Lenalidomide?
Lenalidomide, the active ingredient in Lenalidomid Teva, is an immunomodulatory drug (IMiD) presented as an oral formulation for oral use. It treats multiple myeloma, myelodysplastic syndromes and mantle cell lymphoma in adult patients.
GNH USA supplies Lenalidomid Teva as a licensed, GDP-compliant international pharmaceutical supplier serving hospitals, oncology centres, pharmacies and clinics worldwide.
What is Lenalidomide used for?
Lenalidomid Teva is an immunomodulatory agent used in hematologic malignancies.
Multiple Myeloma: improves progression‑free survival and disease control in adult patients. Myelodysplastic Syndromes: reduces transfusion dependence and improves blood counts in patients with del(5q) cytogenetic abnormality. Mantle Cell Lymphoma: contributes to disease remission when used in combination therapy for adult patients.
What are the side effects of Lenalidomide?
Lenalidomid Teva may cause a range of adverse reactions.
Common Side Effects: - Fatigue - Neutropenia - Thrombocytopenia - Diarrhea - Rash - Anemia
Serious or Rare Side Effects: - Venous thromboembolism - Secondary primary malignancies - Severe neutropenia with infection risk - Hepatic toxicity - Tumor lysis syndrome - Interstitial lung disease
What precautions apply to Lenalidomide?
Use of Lenalidomid Teva requires careful monitoring and patient counseling.
Monitor blood counts: perform regular CBC to detect cytopenias. Assess for thrombotic risk: evaluate history of clotting disorders. Avoid use in pregnancy: drug is teratogenic; ensure effective contraception. Adjust dose in renal impairment: follow prescribing guidelines for reduced renal function. Store at ambient temperature: keep below 25°C in original container, protect from moisture.
What does Lenalidomide interact with?
Lenalidomid Teva can interact with other medicines, affecting safety or efficacy.
Major Interactions (Avoid): - Strong CYP3A4 inhibitors: may increase lenalidomide exposure. - Anticoagulants: increased risk of bleeding. - Live vaccines: risk of infection due to immunosuppression.
Moderate Interactions (Monitor Closely): - CYP3A4 inducers: may reduce therapeutic effect. - Other myelosuppressive agents: monitor blood counts closely. - HIV protease inhibitors: may alter drug metabolism.
Frequently asked questions
What conditions is Lenalidomid Teva used for?+
How does lenalidomide work in the body?+
What is the usual dose of Lenalidomid Teva?+
Is Lenalidomid Teva safe during pregnancy or breastfeeding?+
How do I order Lenalidomid Teva from GNH USA?+
How does Lenalidomid Teva compare with other treatments for multiple myeloma?+
What are the recommended storage conditions for Lenalidomid Teva?+
How is Lenalidomid Teva administered?+
What are the most serious risks associated with Lenalidomid Teva?+
Who should not use Lenalidomid Teva?+
Product details
Related products

A
Liquid Extract From Viscum Album Subsp. Abietis Var Abies Alba (1:20), Extraction Solvents: Water Fo

A
Liquid Extract From Viscum Album Subsp. Abietis Var Abies Alba (1:20), Extraction Solvents: Water Fo

A
Liquid Extract From Viscum Album Subsp. Abietis Var Abies Alba (1:20), Extraction Solvents: Water Fo

A
Liquid Extract From Viscum Album Subsp. Abietis Var Abies Alba (1:20), Extraction Solvents: Water Fo